Regeneron Pharmaceuticals
REGN
$822.96
Share price
-1.39%
Change (1 day)
18.96%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Total assets
Total assets on the balance sheet as of June 2023 : $30.65 B
According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are $30.65 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $29.21 B | 14.86% |
| 2021-12-31 | $25.43 B | 48.19% |
| 2020-12-31 | $17.16 B | 15.93% |
| 2019-12-31 | $14.80 B | 26.17% |
| 2018-12-31 | $11.73 B | 33.89% |
| 2017-12-31 | $8.76 B | 25.68% |
| 2016-12-31 | $6.97 B | 24.32% |
| 2015-12-31 | $5.60 B | 44.87% |
| 2014-12-31 | $3.87 B | 31.2% |
| 2013-12-31 | $2.95 B | 41.84% |
| 2012-12-31 | $2.08 B | 57.19% |
| 2011-12-31 | $1.32 B | 21.49% |
| 2010-12-31 | $1.08 B | 46.98% |
| 2009-12-31 | $0.74 B | 10.62% |
| 2008-12-31 | $0.67 B | -28.43% |
| 2007-12-31 | $0.93 B | 60.02% |
| 2006-12-31 | $0.58 B | 38.16% |
| 2005-12-31 | $0.42 B | -10.49% |
| 2004-12-31 | $0.47 B | -1.34% |
| 2003-12-31 | $0.47 B | 22.47% |
| 2002-12-31 | $0.39 B | -20.96% |
| 2001-12-31 | $0.49 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $195.96 B | 539.22% | 🇺🇸 USA |
 Novartis NVS | $110.97 B | 262.00% | 🇨🇭 Switzerland |
 Amgen AMGN | $90.26 B | 194.44% | 🇺🇸 USA |
 Sanofi SNY | $136.23 B | 344.37% | 🇫🇷 France |
 Biogen BIIB | $25.15 B | -17.94% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.40 B | -88.90% | 🇺🇸 USA |